North American Society for Pediatric Gastroenterology, Hepatology, And

Total Page:16

File Type:pdf, Size:1020Kb

North American Society for Pediatric Gastroenterology, Hepatology, And Journal of Pediatric Gastroenterology and Nutrition 45:E1–E90 # 2007 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Abstracts North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Annual Meeting October 25–27, 2007 Salt Lake City, Utah POSTER SESSION I colon. Furthermore, the patient’s colitis is indeterminate. THURSDAY, OCTOBER 25, 2007 Although no known patient with DC-associated IBD has ever been treated with infliximab, the patient has shown signifi- 5:00 PM – 7:00 PM cant improvement on this regimen. This case has significant implications for the role of the fecal stream in the pathogenesis of Intestine/Colon/IBD IBD and illustrates the systemic dimensions of a local disease. 1 2 INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH A NEOVAGINA IN A PEDIATRIC PATIENT IS CBir1 A PREDICTOR OF PEDIATRIC Jonathan M. Gisser, Rebekah Slocum, Robert L. Parry, INFLAMMATORY BOWEL DISEASE? Jeffrey A. Morganstern1, Taaha Shakir2, Anupama Chawla1. Raymond W. Redline, Gisela G. Chelimsky, Reinaldo 1 Pediatrics, University Hospital Rainbow Pediatrics, Division of Gastroenterology, Stony Brook Garcia-Naveiro. 2 Babies and Children’s Hospital, Cleveland, OH. University Medical Center, Pediatrics, Stony Brook, NY. Case: A 30-month-old caucasian girl presented with a one week Aim: Review charts of all pediatric patients at Stony Brook history of abdominal pain, fever, hematochezia and vaginal University Medical Center who underwent CBir1 (anti-flagellin) discharge. She had a congenital cloacal malformation that was testing to assess its diagnostic value for inflammatory bowel repaired in infancy with construction of a neovagina made from disease (IBD). a segment of her descending colon and a rectal pull-through. Methods: Forty patients were tested for the CBir1 marker since On admission, she was passing bloody stools from her it became available. Ages ranged from 6–19 and genders neorectum, and a bloody discharge from her partially prolapsed were 48% male, 52% female. The most common indications neovagina. She had hypoalbuminemia, leukocytosis and a were abdominal pain, irregular bowel habits, and hematochezia. markedly elevated inflammatory bowel disease (IBD) serolo- Sensitivity, specificity, and positive/negative predictive values gical marker (pANCA 192 EU/ml). Endoscopic examination were calculated. Diagnosis was based on interpretation of the revealed gastritis, duodenitis and colitis consistent with IBD. complete workup by a pediatric gastroenterologist. Her neovaginal inflammation, however, was more severe than Results: Twenty patients (50%) had positive CBir1 antibodies, her colonic disease. After a prolonged course, complicated above the cutoff of 21 EU/mL. Of this subgroup, 9 were diag- by Clostridium difficile neovaginitis and a poor response to nosed with IBD (PPV 45%). Seven of these 9 were also positive immunomodulator therapy with azathioprine, she improved for one of the more traditional markers (ASCA/OmpC/pANCA). on a regimen of subcutaneous methotrexate, intravenous inflix- Ten patients were positive for only CBir1, with no other IBD imab, and topical metronidazole to her neovagina. markers. In this group, only two patients were diagnosed with Discussion: This is an unusual case of probable diversion colitis IBD (PPV 20%). Eleven (48%) of the 23 patients without IBD (DC) associated with IBD. DC involves a segment of bowel were CBir1 positive. that has been diverted from the alimentary tract, such as a Conclusion: CBir1 is a poor predictor for IBD, compared to neovagina, and is treated by restoring bowel continuity. It is a ASCA. Combining the two markers improved overall sensi- relatively common occurrence among patients with sigmoid tivity and negative predictive value but specificity and positive neovaginas. However, there are only five reported cases of adult predictive value remained low. The above data are limited by patients with DC developing ulcerative colitis in the in-stream sample size and the duration offollow-up; therefore, evaluation of bowel. Ours is the youngest case of DC-associated IBD, and the a larger cohort of patients is warranted. While CBir1 may have only one involving the stomach and small bowel, in addition to the other uses, its utility as a diagnostic test for IBD in the pediatric patient appears to be limited due to a large number of false positive results. Until further studies are completed, we recom- ÃPosters of Distinction. mend exercising caution in interpreting positive CBir1 results. E1 E2 Background: Serum antibodies are associated with Crohn’s CBir1 ASCA ASCA + CBir1 disease (CD), correlate with disease location, and predict dis- Sensitivity 53% 41% 76% ease phenotype. The aim of this study was to determine Specificity 52% 96% 52% relationships between serum antibodies and growth parameters PPV 45%à 88% 54% in newly diagnosed pediatric CD. NPV 60% 69% 75% Methods: A retrospective review was conducted on children ÃPPV of CBir1 in patients with no other positive markers is 20%. diagnosed with CD from 2003–6. All children who underwent IBD First Step (Prometheus Laboratories, Inc.; San Diego, CA) were included. Height (Ht), weight (Wt), and BMI prior to diagnosis and therapy were converted to Z-scores for age 3 and gender. Children with IBD Predicted, CD Predicted, GASTROINTESTINAL NOROVIRUS INFECTION and children with the presence of specific antibodies were ASSOCIATED WITH EXACERBATION OF compared to children with IBD Not Predicted using unpaired INFLAMMATORY BOWEL DISEASE t-tests. John N. Udall, Raheel R. Khan, Amana N. Nasir, Kathleen J. Results: 72 patients met inclusion criteria. Newly diagnosed Martin, April D. Lawson. Pediatrics, WVU Health Sciences CD patients with IBD Predicted and/or CD Predicted results had Center, Charleston Division, Charleston, WV. significantly decreased Ht and Wt Z-scores compared to newly diagnosed CD patients with IBD Not Predicted result. Patients Introduction: Norovirus is a common cause of acute gastro- with a positive ASCA IgA or IgG had significantly decreased enteritis in children and adults. The pathogenesis of Norovirus Wt and BMI Z-scores compared to those with IBD Not infection is poorly understood because the virus does not grow Predicted. Patients with a positive Anti-OmpC IgA had a well in cultured cells, and there is no commonly accepted small significantly decreased Ht Z-score compared to those with animal model to study the virus (Science 2003; 299:1575–8). IBD Not Predicted. Patients with a positive pANCA did not Infectious agents may be associated with exacerbations of inflam- differ from patients with IBD Not Predicted. matory bowel disease (IBD); however, there have been no reports Discussion: This study correlates growth parameters at diagnosis suggesting Norovirus may be associated with the disease. with serum antibodies in children with inflammatory bowel Methods: We performed a retrospective chart review of 8 IBD disease, and provides evidence that certain subsets of chil- patients with exacerbations since November 2006. We ident- dren diagnosed with CD are at greater risk of growth ified those with Norovirus documented by the presence of impairment. Norovirus antigen in stool samples and/or rectal swabs. Type of IBD, gender, age, presence or absence of diarrhea/hemato- Mean Anthropometric Z-scores in Patients With Newly chezia and the need for hospitalization was assessed. The charts Diagnosed Crohn’s Disease of six non-IBD patients seen in clinic who had Norovirus positive diarrhea were used as controls. IBD first step n Mean height Mean weight Mean BMI Results: Of the IBD patients; 6 had UC, 1 had CD and 1 panel result z-score z-score z-score indeterminate colitis. All eight IBD patients presented with bloody diarrhea. Two patients also had other pathogens in the All Patients 72 À0.33 À0.54 À0.41 stool including adenovirus and/or Clostridium difficile at the IBD Not Predicted 14 0.29 0.08 À0.08 à à IBD Predicted 58 À0.50 À0.69 À0.49 time they tested positive for Norovirus. All control group à à CD Predicted 51 À0.61 À0.99 À0.82 patients experienced diarrhea, however no hematochezia was à à ASCA IgA + 37 À0.40 À0.77 À0.69 noted. No control group patients required hospitalization. à à ASCA IgG + 24 À0.32 À0.97 À0.90 Conclusion: We conclude that Norovirus may be associated à OmpC IgA+ 21 À0.80 À0.88 À0.28 with exacerbations of IBD. When Norovirus accompanies IBD pANCA + 18 0.19 À0.26 À0.27 it appears more likely to be associated with hematochezia and à require hospitalization than when the infection occurs in the P < 0.05 compared to IBD Not Predicted. absence of IBD. Whether the virus initiates or contributes to the severity of an exacerbation or is a ‘‘bystander’’ during an exacerbation is not known. 5 AN EDUCATION PROGRAM FOR ADOLESCENTS Mean age Hospital WITH INFLAMMATORY BOWEL DISEASE Groups Sex (range) Diarrhea Hematochezia admission Lynelle M. Boamah1, Janet Bohren2, Raymond Baker1, Susan Moyer1. 1Cincinnati Children’s Hospital, Cincinnati, OH; IBD 5M/3F 14 y (10–17 y) 8 of 8 8 of 8 4 of 8 2University of Cincinnati. Non-IBD 5M/1F 13 y (10–18 y) 6 of 6 0 of 6 0 of 6 Background: 25% of patients with inflammatory bowel disease 4 (IBD) are diagnosed in childhood, particularly adolescence. Adolescents lack IBD-specific knowledge. There are no edu- SERUM ANTIBODIES AND GROWTH PARAMETERS cational programs for adolescent patients with IBD. AT DIAGNOSIS IN PEDIATRIC CROHN’S DISEASE Hypothesis: A well-designed education program for adoles- Anna Trauernicht, Steven Steiner. Indiana University School of cents with IBD using an interactive CD-ROM will significantly Medicine, Indianapolis. improve IBD-specific knowledge. J Pediatr Gastroenterol Nutr, Vol. 45, No. 4, October 2007 E3 Methods: IRB approval and informed consent/assent was Background: The diagnosis of Inflammatory Bowel Disease obtained. Assessment of baseline IBD knowledge was performed (IBD) is based typically on endoscopy and mucosal biopsy.
Recommended publications
  • Utility of the Digital Rectal Examination in the Emergency Department: a Review
    The Journal of Emergency Medicine, Vol. 43, No. 6, pp. 1196–1204, 2012 Published by Elsevier Inc. Printed in the USA 0736-4679/$ - see front matter http://dx.doi.org/10.1016/j.jemermed.2012.06.015 Clinical Reviews UTILITY OF THE DIGITAL RECTAL EXAMINATION IN THE EMERGENCY DEPARTMENT: A REVIEW Chad Kessler, MD, MHPE*† and Stephen J. Bauer, MD† *Department of Emergency Medicine, Jesse Brown VA Medical Center and †University of Illinois-Chicago College of Medicine, Chicago, Illinois Reprint Address: Chad Kessler, MD, MHPE, Department of Emergency Medicine, Jesse Brown Veterans Hospital, 820 S Damen Ave., M/C 111, Chicago, IL 60612 , Abstract—Background: The digital rectal examination abdominal pain and acute appendicitis. Stool obtained by (DRE) has been reflexively performed to evaluate common DRE doesn’t seem to increase the false-positive rate of chief complaints in the Emergency Department without FOBTs, and the DRE correlated moderately well with anal knowing its true utility in diagnosis. Objective: Medical lit- manometric measurements in determining anal sphincter erature databases were searched for the most relevant arti- tone. Published by Elsevier Inc. cles pertaining to: the utility of the DRE in evaluating abdominal pain and acute appendicitis, the false-positive , Keywords—digital rectal; utility; review; Emergency rate of fecal occult blood tests (FOBT) from stool obtained Department; evidence-based medicine by DRE or spontaneous passage, and the correlation be- tween DRE and anal manometry in determining anal tone. Discussion: Sixteen articles met our inclusion criteria; there INTRODUCTION were two for abdominal pain, five for appendicitis, six for anal tone, and three for fecal occult blood.
    [Show full text]
  • 16. Questions and Answers
    16. Questions and Answers 1. Which of the following is not associated with esophageal webs? A. Plummer-Vinson syndrome B. Epidermolysis bullosa C. Lupus D. Psoriasis E. Stevens-Johnson syndrome 2. An 11 year old boy complains that occasionally a bite of hotdog “gives mild pressing pain in his chest” and that “it takes a while before he can take another bite.” If it happens again, he discards the hotdog but sometimes he can finish it. The most helpful diagnostic information would come from A. Family history of Schatzki rings B. Eosinophil counts C. UGI D. Time-phased MRI E. Technetium 99 salivagram 3. 12 year old boy previously healthy with one-month history of difficulty swallowing both solid and liquids. He sometimes complains food is getting stuck in his retrosternal area after swallowing. His weight decreased approximately 5% from last year. He denies vomiting, choking, gagging, drooling, pain during swallowing or retrosternal pain. His physical examination is normal. What would be the appropriate next investigation to perform in this patient? A. Upper Endoscopy B. Upper GI contrast study C. Esophageal manometry D. Modified Barium Swallow (MBS) E. Direct laryngoscopy 4. A 12 year old male presents to the ER after a recent episode of emesis. The parents are concerned because undigested food 3 days old was in his vomit. He admits to a sensation of food and liquids “sticking” in his chest for the past 4 months, as he points to the upper middle chest. Parents relate a 10 lb (4.5 Kg) weight loss over the past 3 months.
    [Show full text]
  • A Pediatrician's Guide to Constipation
    5/8/2018 Pediatric Upsies, Downsies and Oopsies – Diarrhea and Constipation GLENN DUH, M.D. PEDIATRIC GASTROENTEROLOGY KP DOWNEY (TRI-CENTRAL) I have nothing to disclose Objectives Identify the pertinent history information regarding the symptoms of diarrhea, constipation and rectal bleeding. Identify the “red flags“ associated with symptoms of constipation, and diarrhea and rectal bleeding. Describe indicate the workup/treatment/ management of diarrhea, constipation and rectal bleeding. 1 5/8/2018 First things first…what do you mean by “diarrhea”? Stools too soft or loose? Watery stools? Too much coming out? Undigested food in the stools? Soiling accidents with creamy peanut buttery poop in the underwear? Pooping too many times a day? Waking up at night to defecate? Do not assume that we all use the word the same way! First things first…what do you mean by “constipation”? Stools too hard? Bleeding? No poop for a week? Sits on toilet all day and nothing comes out? Stomachaches? KUB showing colon overstuffed with stuff? Do not assume that we all use the word the same way! It’s kind of gross to talk or think about this… 2 5/8/2018 Yummy… Diarrhea NOW THAT WE’VE LOOSENED THINGS UP A BIT…. What is diarrhea? Definition with numbers 3 or more loose stools a day > 10 mL/kg or > 200 grams of stools per day (not sure how one figures this one in the office) Longer than 14 days – chronic diarrhea The “eyeball” test If it looks like a duck, quacks like a duck, waddles like a duck… It doesn’t look like something else 3 5/8/2018 Acute vs.
    [Show full text]
  • Guide to Treating Your Child's Daytime Or Nighttime Accidents
    A GUIDE TO TREATING YOUR CHILD’S Daytime or Nighttime Accidents, Urinary Tract Infections and Constipation UCSF BENIOFF CHILDREN’S HOSPITALS UROLOGY DEPARTMENT This booklet contains information that will help you understand more about your child’s bladder problem(s) and provides tips you can use at home before your first visit to the urology clinic. www.childrenshospitaloakland.org | www.ucsfbenioffchildrens.org 2 | UCSF BENIOFF CHILDREN’S HOSPITALS UROLOGY DEPARTMENT Table of Contents Dear Parent(s), Your child has been referred to the Pediatric Urology Parent Program at UCSF Benioff Children’s Hospitals. We specialize in the treatment of children with bladder and bowel dysfunction. This booklet contains information that will help you understand more about your child’s problem(s) and tips you can use at home before your first visit to the urology clinic. Please review the sections below that match your child’s symptoms. 1. Stool Retention and Urologic Problems (p.3) (Bowel Dysfunction) 2. Bladder Dysfunction (p.7) Includes daytime incontinence (wetting), urinary frequency and infrequency, dysuria (painful urination) and overactive bladder 3. Urinary Tract Infection and Vesicoureteral Reflux (p. 10) 4. Nocturnal Enuresis (p.12) Introduction (Nighttime Bedwetting) It’s distressing to see your child continually having accidents. The good news is that the problem is very 5. Urologic Tests (p.15) common – even if it doesn’t feel that way – and that children generally outgrow it. However, the various interventions we offer can help resolve the issue sooner THIS BOOKLET ALSO CONTAINS: rather than later. » Resources for Parents (p.16) » References (p.17) Childhood bladder and bowel dysfunction takes several forms.
    [Show full text]
  • Jaundice Jaundice Is Clinically Apparent When Important
    JAUNDICE Jaundice is clinically apparent when important. The clinician needs to educate hemolytic hyperbilirubinemia with normal hypotonia, vomiting, high-pitched cry, for α-1 Antitrypsin deficiency, Alagille there is a yellowish discoloration of the the family on symptoms of dehydration liver histology); Dubin-Johnson syndrome hyperpyrexia, seizures, paresis of gaze, syndrome, FIC1 deficiency, BSEP skin, sclera, and mucous membranes and secondary to inadequate breastmilk intake (autosomal recessive disorder that causes oculogyric crisis, and death. Milder forms of deficiency, and MDR3 deficiency. Further is evident when the total bilirubin level and poor feeding. When jaundice persists an increase of conjugated bilirubin without bilirubin encephalopathy include cognitive imaging options include cholangiogram, rises above 4-5 mg/dl in infants and 3 beyond two weeks after birth, cholestasis elevation of liver enzymes); Biliary atresia dysfunction and learning disabilities. CT, MRI, ERCP, and/or liver biopsies. mg/dl in older children. It is important or conjugated hyperbilirubinemia must be (improper opening of bile ducts which leads Initial diagnostic evaluation for Treatment options for moderate to severe to identify the cause of excess bilirubin considered in the differential diagnoses. to bile accumulation); Alpha-1 antitrypsin unconjugated hyperbilirubinemia jaundice consist of: alteration of breast- in order to initiate appropriate treatment. Neonatal cholestasis is defined as a direct deficiency (genetic disorder that causes may include: complete blood count, feeding with formula feeding; Phototherapy Elevated bilirubin levels should always be bilirubin level of ≥ 2 mg/dl and ≥ 20% defective production of A1AT that protects reticulocytes, direct and indirect Coombs to change the shape and structure of the fractionated into unconjugated (indirect) or Youhanna Al-Tawil , MD of the total bilirubin level.
    [Show full text]
  • Gastroenterology Request for Service
    GI / Hepatology Request for Service Order Pt. Name:_______________________________________________________ Referring Provider Name: __________________________________ DOB:___________________________________________________________ Practice Name:___________________________________________ MRN (If available):________________________________________________ Date of Request:__________________________________________ Parent Name____________________________________________________ Phone #______________________Preferred time: ☐ 8-12, ☐ 12-5, ☐ after 5 Insurance: ☐ Medicaid, ☐ PPO, ☐ HMO, ☐ Self-pay / Other *Please attach patient’s demographics* Step 1: When should patient be seen? ☐ ASAP (< 24 hours) For physicians new to Lurie Children’s –Call the VIP Physician Hotline – 800.540.4131, Option 4 For all other physicians, call the Lurie Children’s GI Department Directly at 312.227.4200 ☐Within 2 weeks ☐> 2 weeks Step 2: Identify Chief Complaint ☐ Liver Disease ☐ GI Symptoms ☐ Blood in Stool ☐ Feeding Intolerance Note: If concern for a severe acute liver illness, please page ☐Bloating/Abdominal liver fellow on call ☐ Dysphagia ☐ Hematemesis/Blood ☐ 1 Distention Gallstones * ☐Nausea ☐ Encopresis Loss ☐ Hepatitis B ☐ ☐Vomiting ☐Failure to ☐Inflammatory Bowel Hepatitis C ☐ ☐Diarrhea Thrive/Poor Growth Disease Elevated liver enzymes - obese patient ☐ ☐ Elevated liver enzymes - non-obese Constipation ☐ Family History of ☐ Malabsorption patient ☐GERD Symptoms Colon Cancer/Polyp ☐ 2 ☐Abdominal Pain Neonatal Jaundice/Cholestasis * ☐ Jaundice/elevated
    [Show full text]
  • Gastrointestinal Manifestations of HIV Infection Anthony J
    HIV Curriculum for the Health Professional Gastrointestinal Manifestations of HIV Infection Anthony J. Garcia-Prats, MD George D. Ferry, MD Nancy R. Calles, MSN, RN, PNP, ACRN, MPH Objectives HIV-infected patients. Others include vomiting, wasting, hepatitis, esophagitis, malabsorption, jaundice, and 1. Review specific subjective and objective information failure to thrive. Most of these GI problems are related important in the assessment of nausea, to infections and may be caused by HIV itself or other vomiting, and diarrhea in patients with human viruses such as cytomegalovirus (CMV) and hepatitis B immunodeficiency virus (HIV)/AIDS. and C; by bacteria such as Mycobacterium avium complex 2. Discuss the possible causes of, types of, and (MAC), Salmonella, and Shigella; by parasites such as management approaches to diarrhea in patients with Cryptosporidium and Giardia; and by fungi such as HIV/AIDS. Candida. This module will discuss the causes of the most 3. Classify the signs of dehydration in relation to their common GI manifestations in HIV-infected patients and level of severity. approaches to the assessment and treatment of these 4. Identify the appropriate rehydration plan for use conditions. with patients experiencing dehydration. 5. Describe the specific symptoms associated with Nausea and Vomiting wasting syndrome in patients with HIV/AIDS. 6. Describe the symptoms and causes of hepatitis in Nausea and vomiting are common physical complaints HIV-infected children. with many causes. Causes include infection and/or inflammation of the GI tract, gastroesophageal reflux, Key Points an overfilled stomach, protein intolerance, urinary tract infection, pregnancy, increased intracranial 1. Patients with HIV/AIDS are at high risk of having pressure, meningitis, hepatitis, biliary tract disease, gastrointestinal complications.
    [Show full text]
  • Care of Infants and Children
    AAFP Reprint No. 260 Recommended Curriculum Guidelines for Family Medicine Residents Care of Infants and Children This document was endorsed by the American Academy of Family Physicians (AAFP). Introduction This AAFP Curriculum Guideline defines a recommended training strategy for family medicine residents. Attitudes, behaviors, knowledge, and skills that are critical to family medicine should be attained through longitudinal experience that promotes educational competencies defined by the Accreditation Council for Graduate Medical Education (ACGME), www.acgme.org. The family medicine curriculum must include structured experience in several specified areas. Much of the resident’s knowledge will be gained by caring for ambulatory patients who visit the family medicine center, although additional experience gained in various other settings (e.g., an inpatient setting, a patient’s home, a long-term care facility, the emergency department, the community) is critical for well-rounded residency training. The residents should be able to develop a skillset and apply their skills appropriately to all patient care settings. Structured didactic lectures, conferences, journal clubs, and workshops must be included in the curriculum to supplement experiential learning, with an emphasis on outcomes-oriented, evidence-based studies that delineate common diseases affecting patients of all ages. Patient-centered care, and targeted techniques of health promotion and disease prevention are hallmarks of family medicine and should be integrated in all settings. Appropriate referral patterns, transitions of care, and the provision of cost- effective care should also be part of the curriculum. Program requirements specific to family medicine residencies may be found on the ACGME website. Current AAFP Curriculum Guidelines may be found online at 1 www.aafp.org/cg.
    [Show full text]
  • ENCOPRESIS Information for Children and Parents
    ENCOPRESIS Information for children and parents Children with encopresis have bowel movements in the wrong places, such as underwear and nightclothes. This is called “soiling”. Sometimes the child will also pass stool in the toilet. Encopresis is very common, occurring in at least 1.5% of all children. What do You say? Families use many different words to mean “bowel movement” or “feces”. Does your child say “booboo” or “poop”? Some people say “number 2” or “make”. Doctors tend to say “bowel movement “ or “stool”, which are the words used in this pamphlet. Please let your doctor know what words will help your child to understand SYMPTOMS Encopresis usually follows constipation. The child may have stomach ache, cramps, vomiting, or bloating. Some children become pale or flushed, lose their appetites, or even lose weight. Some have small tears in the anal tissue called anal fissures. These are painful and can lead to blood in the stool. Children with this problem have different bowel habits. Some may not have any bowel movement for many days, and then have a huge, hard stool, large enough to block the toilet! Other children have daily bowel movements on the toilet but also leak liquid, diarrhea-like stool into their clothes. Some children do not stool in the toilet at all. Children may hide their soiled underwear in drawers or under the bed. This can be very unpleasant for other family members. Another common upsetting behavior is refusal to change dirty clothing even though the odor is very annoying to other people. The child with encopresis may not notice the unpleasant smell.
    [Show full text]
  • Outpatient Pediatrics, Continuity Clinic, and Office Based Rotations
    Outpatient Pediatrics, Continuity Clinic, and Office Based Rotations Description of Rotation: Residents on the outpatient rotation will examine and evaluate patients presenting with acute or chronic conditions. Their findings, impressions, and plans will be presented to an attending physician. The attending physician will examine all patients presented by PL-1 residents in their first six months of training. As residents gain more knowledge and experience, they will be given more autonomy. Residents will see their own private patients in their continuity clinic. Each resident will have their continuity clinic one half day per week. This will allow residents to follow patients longitudinally throughout their three years of residency training. These patients may be acquired through the newborn nursery, the emergency room, the inpatient service, or the general pediatric clinic. Responsibilities: Residents will arrive in the clinic at 8 am. They are expected to stay until all patient care and follow-up activities are completed for the day. They will be respectful to the patients, staff, and each other. They are required to attend the resident lecture series. Residents will notify the clinic director and the scheduling clerk if they are going to be absent. In case of vacation or CME, notification of clinic cancellation should occur as early as possible to allow for rescheduling of patients. Note: The goals and objectives described in detail below are not meant to be completed in a single one month block rotation but are meant to be cumulative, culminating in a thorough and complete outpatient experience at the end of residency. Primary Goals for this Rotation GOAL: Health Promotion and Screening.
    [Show full text]
  • 03-Experts on Call-Jan
    Experts on Call Answers to your questions from our medical experts ß-blockers and allergy injections Are ß-blockers contraindicated in patients undergoing allergy injection? ? Submitted by: Beth Vallieres, MD, Cambridge, Ontario Patients with asthma are at higher risk for inhibitors may also be problematic during adverse reactions to immunotherapy com - anaphylaxis, as the blockade of ACE pared to rhinitis, particularly if not well con - inhibitors prevents the compensatory trolled. Additional risk factors that have been release of angiotensin, a potent vasoncon - identified in patients experiencing fatal reac - stricto©r during hypotension, whicth isoassoci - ht ribu tions are: ig ated with anaphyilasxist. Theraefdo,re, immuno- r D wnlo • dosage errors, py therapiyashlould ncedrotainly be avoided in o rc rs ca use • first injection from aCnew vial of extract epatientussreequiringonß-abllockers and perhaps m ised ers and om thorACE blofcokrinpg agents as well. C . Au opy • use of ß-blocking agoentrs. 1 ited le c e ohib sing al pr t a Reference The probleSm stems unsoet from apnriinncreased for rised and 1. Reid MJ, Lockey RF, Turkeltaub PC, et al: Survey of fatalities from trisk of aunthaollergic rveiaecwtion or anaphylaxis skin testing and immunotherapy 1985-1989. J Allergy Clin o Una lay, N from the dinisjepction, but from the difficulty Immunol 1993; 92(1 Pt 1):6-15. in treating such a reaction, as these patients can be very resistant to standard regimens. Similarly, angiotensin converting enzyme (ACE) Answered by: Dr. Tom Gerstner Contraindicated treatments in sleep apnea and CHF Are there any treatments that are contraindicated in patients with both sleep ? apnea and CHF? Submitted by: Louis G.
    [Show full text]
  • Chapter 4: Gastrointestinal, Hepatic, and Nutritional Problems
    Fanconi Anemia: Guidelines for Diagnosis and Management Chapter 4: Gastrointestinal, Hepatic, and Nutritional Problems Introduction Good to Know The gastrointestinal system digests food and absorbs the nutrients our bodies need to function properly. This system is a complex group of cells organized as a long, hollow tube that begins at the mouth, continues through the esophagus, stomach, and intestines, and ends at the anus. The liver aids digestion by producing bile, which helps the body break down fats. The liver also clears some toxins from the body and synthesizes certain nutrients. Both Fanconi anemia (FA) and medications used to treat the disease can cause gastrointestinal disorders, liver disease, and nutrition-related challenges. Many patients experience symptoms such as reduced appetite, nausea, abdominal pain, and diarrhea. Without proper treatment, these symptoms can interfere with daily living and create hurdles to healthy growth and development. Concerns related to the gastrointestinal tract most commonly include: • Abnormalities of the gastrointestinal tract • Gastrointestinal symptoms, including poor food intake, nausea, abdominal pain, and/or diarrhea • Poor weight gain or malnutrition, often resulting from reduced food intake or difficulty absorbing nutrients from food • Overweight or obesity • Cancers of the gastrointestinal tract • Liver disease • Gastrointestinal-related complications of hematopoietic stem cell transplant (HSCT) 74 Chapter 4: Gastrointestinal, Hepatic, and Nutritional Problems The gastrointestinal clinical care team should include a gastroenterologist or pediatric gastroenterologist and, when needed, a dietician. This team should work in close collaboration with other FA specialists to provide comprehensive care. The involvement of multiple types of providers in the care of patients with FA introduces the risk that medications prescribed by one physician might adversely interact with those prescribed by another.
    [Show full text]